Clinical trials
Phase 1 Hematologic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 11 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 16 |
| Recruiting | 15 |
| Not yet recruiting | 11 |
| Completed | 9 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 4 |
| iCell Gene Therapeutics | 4 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 2 |
| He Huang | 2 |
| Nanjing Miracle Biotechnology Co., Ltd. | 2 |
| Qilu Pharmaceutical Co., Ltd. | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| Zhejiang University | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 57 |
| Recurrence | 11 |
| Neoplasms | 7 |
| Leukemia | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Hematologic Diseases | 4 |
| Lymphoma | 4 |
| Multiple Myeloma | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Myelodysplastic Syndromes | 2 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.